President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.

The global smart insulin pens market, currently estimated at US$ 3,927.3 million in 2023, is projected to exhibit robust ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

New Delhi, Jan. 01, 2025 (GLOBE NEWSWIRE) -- According to the latest study from Astute Analytica, the Argentina diabetes devices market is projected to hit the market valuation of US$ 1,031.89 million ...

Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

Shares of drugmaker Novo Nordisk (NVO) sold off sharply last week, falling as much as 29% intraday Friday (before closing down 17%) and wiping out nearly $100B of market value in the process when ...

Novo Nordisk’s Ozempic and Wegovy are based on the active ingredient semaglutide, which mimics a hormone known as GLP-1 that’s important for insulin secretion, digestion and appetite.

(CNN) — Since Ozempic blasted onto the stage in 2017 with its approval for type 2 diabetes, drugmakers Novo Nordisk and Eli Lilly have been battling to leapfrog each other with newer and more ...

These medications: increase insulin production slow the speed at ... you can get Ozempic for as little as $25 with a Novo Nordisk savings card. Those without insurance can expect to pay around ...